Apollon Wealth Management LLC Purchases New Shares in Waters Co. (NYSE:WAT)

Apollon Wealth Management LLC bought a new stake in shares of Waters Co. (NYSE:WAT - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,920 shares of the medical instruments supplier's stock, valued at approximately $961,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. IMPACTfolio LLC lifted its stake in shares of Waters by 4.2% in the 4th quarter. IMPACTfolio LLC now owns 803 shares of the medical instruments supplier's stock valued at $264,000 after purchasing an additional 32 shares during the last quarter. Mountain Pacific Investment Advisers Inc. ID lifted its position in Waters by 0.3% in the fourth quarter. Mountain Pacific Investment Advisers Inc. ID now owns 11,469 shares of the medical instruments supplier's stock valued at $3,776,000 after buying an additional 34 shares during the last quarter. Summit Trail Advisors LLC boosted its stake in Waters by 3.9% during the third quarter. Summit Trail Advisors LLC now owns 1,180 shares of the medical instruments supplier's stock worth $324,000 after buying an additional 44 shares during the period. Tokio Marine Asset Management Co. Ltd. raised its stake in shares of Waters by 3.6% in the 4th quarter. Tokio Marine Asset Management Co. Ltd. now owns 1,413 shares of the medical instruments supplier's stock valued at $465,000 after acquiring an additional 49 shares during the period. Finally, Sequoia Financial Advisors LLC boosted its position in shares of Waters by 5.6% during the 3rd quarter. Sequoia Financial Advisors LLC now owns 937 shares of the medical instruments supplier's stock worth $257,000 after purchasing an additional 50 shares during the period. Hedge funds and other institutional investors own 94.01% of the company's stock.

Insider Activity at Waters

In other Waters news, Director Linda Baddour sold 500 shares of Waters stock in a transaction that occurred on Wednesday, March 13th. The stock was sold at an average price of $355.54, for a total transaction of $177,770.00. Following the transaction, the director now owns 2,250 shares of the company's stock, valued at $799,965. The transaction was disclosed in a filing with the SEC, which is available at this link. Insiders own 0.82% of the company's stock.

Waters Stock Up 4.4 %

Waters stock traded up $14.69 during mid-day trading on Friday, hitting $351.11. The company had a trading volume of 791,032 shares, compared to its average volume of 439,872. The stock has a market cap of $20.82 billion, a price-to-earnings ratio of 32.36, a PEG ratio of 6.36 and a beta of 0.98. The company has a quick ratio of 1.57, a current ratio of 2.22 and a debt-to-equity ratio of 2.00. Waters Co. has a 1 year low of $231.90 and a 1 year high of $363.80. The business has a fifty day moving average of $333.03 and a 200 day moving average of $311.69.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Tuesday, May 7th. The medical instruments supplier reported $2.21 EPS for the quarter, topping the consensus estimate of $2.10 by $0.11. The firm had revenue of $636.80 million for the quarter, compared to analyst estimates of $635.57 million. Waters had a net margin of 21.72% and a return on equity of 81.30%. Waters's revenue for the quarter was down 7.0% compared to the same quarter last year. During the same period last year, the business earned $2.49 EPS. On average, sell-side analysts expect that Waters Co. will post 11.89 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on WAT shares. Robert W. Baird lowered their price target on Waters from $319.00 to $312.00 and set a "neutral" rating for the company in a research report on Wednesday. TD Cowen boosted their price target on shares of Waters from $350.00 to $358.00 and gave the stock a "hold" rating in a research note on Wednesday. Stifel Nicolaus lifted their price objective on shares of Waters from $330.00 to $332.00 and gave the company a "hold" rating in a report on Wednesday. Evercore ISI increased their target price on shares of Waters from $320.00 to $340.00 and gave the stock an "in-line" rating in a report on Thursday, April 4th. Finally, Barclays dropped their price target on shares of Waters from $300.00 to $295.00 and set an "underweight" rating for the company in a research note on Wednesday. One analyst has rated the stock with a sell rating and ten have issued a hold rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Hold" and a consensus target price of $306.70.

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.